Cargando…
Diagnostic Accuracy of Blood-based Biomarkers for Pancreatic Cancer: A Systematic Review and Meta-analysis
Pancreatic ductal adenocarcinoma (PDAC) has a 5-year survival rate below 5%. Carbohydrate antigen 19-9 (CA19-9) is the most commonly used blood-based biomarker for PDAC in current clinical practice, despite having been shown repeatedly to be inaccurate and have poor diagnostic performance. This revi...
Autores principales: | Kane, Laura E., Mellotte, Gregory S., Mylod, Eimear, O'Brien, Rebecca M., O'Connell, Fiona, Buckley, Croí E., Arlow, Jennifer, Nguyen, Khanh, Mockler, David, Meade, Aidan D., Ryan, Barbara M., Maher, Stephen G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035398/ https://www.ncbi.nlm.nih.gov/pubmed/36969742 http://dx.doi.org/10.1158/2767-9764.CRC-22-0190 |
Ejemplares similares
-
Multi-Omic Biomarkers as Potential Tools for the Characterisation of Pancreatic Cystic Lesions and Cancer: Innovative Patient Data Integration
por: Kane, Laura E., et al.
Publicado: (2021) -
The Omentum in Obesity-Associated Cancer: A Hindrance to Effective Natural Killer Cell Migration towards Tumour Which Can Be Overcome by CX3CR1 Antagonism
por: Mylod, Eimear, et al.
Publicado: (2021) -
A comparison of the efficacy of transplantation of bone marrow-derived mesenchymal stem cells and unrestricted somatic stem cells on outcome after acute myocardial infarction
por: Flynn, Aidan, et al.
Publicado: (2012) -
Metformin is a metabolic modulator and radiosensitiser in rectal cancer
por: Buckley, Croí E., et al.
Publicado: (2023) -
Gastrointestinal side effects of cancer
treatments
por: O’Reilly, Mary, et al.
Publicado: (2020)